Tech Company Financing Transactions
Deka Biosciences Funding Round
Deka Biosciences, based in Germantown, secured $20 million from MPM Capital, Alexandria Venture Investments and Amana Investments.
Transaction Overview
Company Name
Announced On
9/28/2023
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
MPM Capital (Lead Investor) (Detlev Biniszkiewicz)
Proceeds Purpose
The company intends to use the funds to support the advancement of its pipeline and drug product manufacturing as they continue clinical trials following the receipt of a notice to proceed letter from the FDA for their investigational new drug (IND) application to evaluate DK210 (EGFR).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20271 Goldenrod Ln
Germantown, MD 20876
USA
Germantown, MD 20876
USA
Phone
Undisclosed
Website
Email Address
Overview
The Diakine� platform is a next-generation cytokine therapy created to treat cancer and inflammatory diseases based on each patient's individual immune response. Our platform harnesses the potential of the immune system by empowering it to safely combat inflammatory disease and cancer. It is the first therapy to combine two anti-inflammatory cytokines for inflammatory disease, or to combine an immune stimulating cytokine and an anti-inflammatory cytokine into a single treatment for cancer. Through targeting, these powerful cytokine combinations enrich in the affected tissue with the potential to drive disease control.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Mumm
Chief Medical Officer
Charlotte Moser
Browse more venture capital transactions:
Prev: 9/28/2023: Nexusflow venture capital transaction
Next: 9/28/2023: Partum Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs